[1]
“Efficacy of Bezlotoxumab in Preventing Recurrent Clostridioides Difficile Infection: A Narrative Review”, AMMS, pp. 1096–1102, Sep. 2025, Accessed: Dec. 24, 2025. [Online]. Available: http://ammspub.com/index.php/amms/article/view/329